Bezafibrate

National NHS prescribing (Prescription Cost Analysis) · Lipid-regulating drugs

Data updated March 2026

Bezafibrate was ranked 388th of 1,794 medicines by items in March 2026, with 21,875 items, down 7.6% on a year earlier.

21,875items

Dispensed in March 2026

NHSBSA Prescription Cost Analysis

£163,572

Net ingredient cost · March 2026

NHSBSA PCA

270,744items

Dispensed in the last 12 months

NHSBSA PCA

Figure 1. Bezafibrate: national items dispensed by month

Source: NHSBSA Prescription Cost Analysis, to March 2026

Download CSV

Embed this chart

<iframe src="https://pharmainsight.co.uk/embed/medicines/bezafibrate-0212000d0" width="100%" height="280" style="border:0" loading="lazy" title="Bezafibrate: NHS prescribing in England — PharmaInsight"></iframe>

Top presentations, March 2026

The individual products dispensed under Bezafibrate, by items this month.

Presentations of Bezafibrate, March 2026
Presentation	Items	Net ingredient cost
Bezafibrate 400mg modified-release tablets	16,108	£131,816
Bezafibrate 200mg tablets	4,656	£22,414
Bezalip Mono 400mg modified-release tablets	1,043	£9,003
Bezalip 200mg tablets	44	£197
Lipozate 400mg modified-release tablets	24	£143

Compare Bezafibrate with

Other medicines in the same BNF section, by prescribing volume.